A new triphenylethylene derivative, TAT-59; hormone receptors; insulin-like growth factor 1; and growth suppression of hormone-dependent MCF-7 tumors in athymic mice-Reference-Cited by-同舟云学术

A new triphenylethylene derivative, TAT-59; hormone receptors; insulin-like growth factor 1; and growth suppression of hormone-dependent MCF-7 tumors in athymic mice

Published:1994 Issue:5 Volume:34 Page:372-376
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Iino Yuichi,Takai Yoshiki,Ando Tatsumasa,Ohwada Susumu,Yokoe Takao,Sugamata Noritaka,Takei Hiroyuki,Horiguchi Jun,Iijima Koutarou,Morishita Yasuo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00685560.pdf

Reference26 articles.

1. Brown RR, Brain R, Jordan VC (1983) Determination of tamoxifen and metabolites in human serum by high-performance liquid chromatography with post column fluorescence activation. J Chromatogr 272: 351

2. Campen CA, Jordan VC, Gorski J (1985) Opposing biological action of antiestrogens in vitro and in vivo: induction of progesterone receptor in mouse uterus. Endocrinology 116: 2327

3. Cancer Research Campaign Adjuvant Breast Trial Working Party (1988) Cyclophosphamide and tamoxifen as adjuvant therapy in the management of breast cancer. Br J Cancer 57: 604

4. Cole MPC, Jones CTA, Todd IDH (1971) A new antiestrogenic agent in late breast cancer. An early clinical appraisal of ICI 46,474. Br. J Cancer 25: 270

5. Fisher B, Constantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Bickerham DL, Fisher ER, Margolese R, Robidoux A, Shibata H, Terz J, Paterson AHG, Feldma MI, Farrar W, Evans J, Lickley HL, Ketner M et al (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor-positive tumors. N Engl J Med 320: 479

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer;Best Practice & Research Clinical Endocrinology & Metabolism;2004-03

2. Selective Estrogen Receptor Modulators: Structure, Function, and Clinical Use;Journal of Clinical Oncology;2000-09-17

3. Antiestrogens and Partial Agonists;Estrogens and Antiestrogens I;1999

4. Molecular mechanisms and future uses of antiestrogens;Molecular Aspects of Medicine;1997-06

5. Clinical potential of new antiestrogens.;Journal of Clinical Oncology;1997-02